tretinoin · Dow Pharm · NDA 209353
Altreno
Earliest generic entry, as listed
22 Aug 2038
Blocked by patent: US 10653656, US 11324710.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10653656 | product, use U-2368 | 22 Aug 2038 |
| US 11324710 | use U-2368 | 22 Aug 2038 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209353 · 001 · RLD | lotion, topical | 0.05% | 22 Aug 2038 |